Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Hospitals
  4. /Indraprastha Medical Corporation Ltd
MomentumDeep Value

Indraprastha Medical Corporation Ltd: Stock Analysis & Fundamentals

Updated this week

Indraprastha Medical Corporation Ltd (Hospitals) — fundamental analysis, earnings data, and key metrics. PE: 19.3. ROE: 30.0%. This stock is not currently in the Nifty 500 momentum outperformers list.

Key Numbers

Current Price
₹385
Dividend Yield
1.17%
Market Cap
3.5K Cr
Valuation
N/A

Other Top Hospitals Stocks Beating Nifty 500

Apollo Hospitals Enterprise Ltd
Average • 6w streak
+17.1%
Aster DM Healthcare Ltd
Weak • 4w streak
+19.7%
KMC Speciality Hospitals (India) Ltd
Average • 12w streak
+15.5%
Sakar Healthcare Ltd
Average • 11w streak
+34.0%
← Back to HospitalsDashboard

Frequently Asked Questions: Indraprastha Medical Corporation Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Indraprastha Medical Corporation Ltd's latest quarterly results?

Indraprastha Medical Corporation Ltd's latest quarterly results (Dec 2025) show

  • PAT Growth YoY: +24.2%
  • Revenue Growth YoY: +14.5%
  • Operating Margin: 17.0%

What is Indraprastha Medical Corporation Ltd's current PE ratio?

Indraprastha Medical Corporation Ltd's current PE ratio is 19.3x.

  • Current PE: 19.3x
  • Market Cap: 3.5K Cr
  • Dividend Yield: 1.17%

What is Indraprastha Medical Corporation Ltd's price-to-book ratio?

Indraprastha Medical Corporation Ltd's price-to-book ratio is 5.4x.

  • Price-to-Book (P/B): 5.4x
  • Book Value per Share: ₹72
  • Current Price: ₹385

Is Indraprastha Medical Corporation Ltd a fundamentally strong company?

Indraprastha Medical Corporation Ltd's fundamental strength based on key financial ratios

  • Return on Capital (ROCE): 39.0%

Is Indraprastha Medical Corporation Ltd debt free?

Indraprastha Medical Corporation Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹33 Cr

What is Indraprastha Medical Corporation Ltd's return on equity (ROE) and ROCE?

Indraprastha Medical Corporation Ltd's return ratios over recent years

  • FY2023: ROCE 34.0%
  • FY2024: ROCE 38.0%
  • FY2025: ROCE 39.0%

Is Indraprastha Medical Corporation Ltd's cash flow positive?

Indraprastha Medical Corporation Ltd's operating cash flow is positive (FY2025).

  • Cash from Operations (CFO): ₹157 Cr
  • Free Cash Flow (FCF): ₹46 Cr
  • CFO/PAT Ratio: 98% (strong cash conversion)

What is Indraprastha Medical Corporation Ltd's dividend yield?

Indraprastha Medical Corporation Ltd's current dividend yield is 1.17%.

  • Dividend Yield: 1.17%
  • Current Price: ₹385

Who holds Indraprastha Medical Corporation Ltd shares — promoters, FII, DII?

Indraprastha Medical Corporation Ltd's shareholding pattern (Dec 2025)

  • Promoters: 51.0%
  • FII (Foreign): 2.7%
  • DII (Domestic): 0.8%
  • Public: 45.4%

Is promoter holding increasing or decreasing in Indraprastha Medical Corporation Ltd?

Indraprastha Medical Corporation Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 51.0% (Dec 2025)
  • Previous Quarter: 51.0% (Sep 2025)
  • Change: 0.00% (stable)

Is Indraprastha Medical Corporation Ltd a new momentum entry or an established outperformer?

Indraprastha Medical Corporation Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Indraprastha Medical Corporation Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Indraprastha Medical Corporation Ltd may be worth studying

  • Cash flow is positive — CFO ₹157 Cr

What is the investment thesis for Indraprastha Medical Corporation Ltd?

Indraprastha Medical Corporation Ltd investment thesis summary:

What is the future outlook for Indraprastha Medical Corporation Ltd?

Indraprastha Medical Corporation Ltd's forward outlook based on current data signals

  • Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.